US › Healthcare

Hookipa Pharma Inc (HOOK)

US · Healthcare · Biotechnology

$1.150.00%

Last close · 2026-08-04

Latest quarter · ended 2025-06-30

Revenue

$6.8M

Revenue YoY

+426.7%

Net profit

$-1.8M

Profit YoY

+90.6%

EPS

$-1.22

EPS estimate

$-1.04

Net margin

-26.3%

EPS came in at -1.22 against a street estimate of -1.04 — a miss of 17.2%.

Key statistics

Market cap

$14.2M

Forward P/E

0.0

P/B

0.50

Book value

$2.71

EPS (TTM)

$-4.83

52-week high

$1.20

52-week low

$0.81

50-day MA

$1.15

200-day MA

$1.00

Beta

0.83

Analyst view

Analysts rate Hookipa Pharma Inc a buy (1 buy, 2 hold, 0 sell out of 3) with an average price target of $2.00.

Shareholding

Insiders

0.12%

Institutions

3.16%

Largest institutional holders

Fund	Stake
JBF Capital, Inc.	0.00%
Acadian Asset Management LLC	0.00%
BNP Paribas Arbitrage, SA	0.00%
Advisor Group Holdings, Inc.	0.00%
XTX Topco Ltd	0.00%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Hookipa Pharma Inc — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc UnitedHealth Group Incorporated Merck & Company Inc Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Novo Nordisk A/S Amgen Inc Abbott Laboratories Gilead Sciences Inc

Data updated 2026-08-05.